Navigation Links
Ansary Symposium on Stem Cell Research at Weill Cornell Medical College
Date:9/16/2008

WHO:

Hosted by Weill Cornell Medical College, the Ansary Symposium on Stem Cell Research is bringing together a group of leading figures in the field, including internationally known scientists, physicians and ethicists, to discuss recent scientific advances and ethical issues in stem cell research.

WHEN:

Wednesday, September 17, 3:00-4:30 PM
- AND -
Thursday, September 18, 8:00 AM-1:30 PM

WHERE:

Uris Auditorium
Weill Cornell Medical College
1300 York Avenue (at 69th Street)

Reporters are invited to attend the two-day symposium. The first day features a lively debate about the future of human embryonic stem cell research. The second day will showcase presentations from the world's top stem cell researchers. The schedule is as follows:

>Wednesday, September 17, 3:00-4:30 PM:

Public Policy Session with Panel Forum

"The Generation and Use of Human Embryonic Stem Cells: What Is the Current Status in the United States, and Where Are We Going?"

Moderated by: Robert Bazell, chief Science and Health Correspondent, NBC News

Featuring:

  • Dr. Arthur Caplan, director, Center for Bioethics, University of Pennsylvania

  • Dr. Christopher Tollefsen, associate professor of Philosophy and Director of Graduate Studies, University of South Carolina

Thursday, September 18, 8:00 AM-1:30 PM:

Scientific Sessions

Five Renowned Scientists Present Cutting Edge Research

  • Dr. Shahin Rafii, co-director, of Ansary Stem Cell Institute at Weill Cornell Medical College will discuss the role of vascular tissue in supporting stem cell and organ regeneration.

  • Dr. Ali Brivanlou, Robert and Harriet Heilbrunn Professor at The Rockefeller University will discuss novel strategies in reprogramming mature cells into pluripotent stem cells<
    '/>"/>

Contact: Andrew Klein
ank2017@med.cornell.edu
212-821-0560
New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics
2. 31st Annual San Antonio Breast Cancer Symposium
3. Southern Sierra Science Symposium planned for Visalia
4. The good, the bad and the smelly: USGS at the 2008 Coral Reef Symposium
5. First-ever symposium brings together military and civilian medical experts
6. York symposium puts focus on chemical weather
7. At Boston symposium, NARSAD researchers report on genes and family traits
8. Decade of the Mind symposium in Iowa to emphasize need for $4 billion in federal support
9. Rockefeller University hosts 2-day evolution symposium, May 1-2, 2008
10. International symposium explores fire suppression economics
11. Symposium on energy research highlights future challenges, opportunities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...el Research Institute (VARI) researchers have dete...id (ABA) works at the molecular level to help plan...ht and cold. Their findings, published in the jou...ve in harsh environments around the world and comb... have implications for stress disorders in humans....
(Date:12/3/2009)...nge in warmer water, according to an intriguing ne...me species more aggressive. , Experiments with t...t Barrier Reef have shown for the first time that ...onsistently bold, and that these individual differ...ise. , A slight lift of just one or two degrees ...
(Date:12/3/2009)...nubbing? Your genetics, not your friends, may be a...-like painkillers, called opioids, relieve not onl...stress. Now, a new study reviewed by Faculty of 10...enetic differences in the gene for the opioid rece...nses to social rejection. , In the study publis...
Breaking Biology News(10 mins):VAI researchers find long awaited key to creating drought resistant crops 2VAI researchers find long awaited key to creating drought resistant crops 3Fish with attitude: Some like it hot 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 1eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 2eCardio Named One of Houstons Fastest Growing Technology Companies at the 2009 Houston Business Journal FastTech 50 Awards Luncheon 6165 3Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 1Regado Biosciences to Present at the Ninth Annual Joint Symposium of BioNJ and Pennsylvania Bio on November 17 2009 6162 2Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 6159 1Executives Reveal Secrets to Capitalize on New Developments in Pharmaceutical Marketing Research 6159 2
...p a clearer picture of what makes some people stan...earchers who last year identified the first common...tified a further twenty regions of the genome whic...cm. , The results, published together with two i...ure Genetics, mean that scientists now know of doz...
...s that desperately try to reach for a break in the...e same affliction: Shade avoidance syndrome or SAS...ght to light by researchers at the Salk Institute ...eighbors shade, plants switch on a natural chemica...rmone auxin that lets a plant grow and ultimately ...
...ute for Medical Research (Burnham) may have found ... showing the link between a certain protein and th...feed breast tumors. Like mortar between bricks in ...tick together and collectively form tissues. Cance...op producing T-cadherin, and in tumors, only the b...
Other Biology News:A tall story: New research adds to growing body of knowledge of genetics of height 2A place in the sun 2A place in the sun 3T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 2T-cadherin affects blood vessel growth in breast cancer, hormone from fat cells may play a role 3
(Date:12/3/2009)...NCISCO, Dec. 3 VIA Pharm... company focused on the development of compounds f...isease, today announced that it has completed the ... trial of VIA-2291. ,, The FDG-PET trial enrol...in the US and Canada including Massachusetts Gener...
(Date:12/3/2009)...LPHIA, Dec. 3 Shire plc ...biopharmaceutical company, today announced a volun...drawal of one lot of the Attention-Deficit/Hyperac...re is taking this action because some Daytrana pat...ir release liner removal specification, and as a r...
(Date:12/3/2009)...IN, Calif., Dec. 3 Pereg...announced that it will release its financial resul...ecember 10, 2009 at 7:00 a.m. EST and will host a ... at 11:30 a.m. EST on the same day. ,, Peregrin...ts for the second quarter ended October 31, 2009 a...
(Date:12/3/2009)..., Mass., Dec. 3 Invernes...al leader in enabling individuals to take charge o... diagnostics and health management, has declared a...rtible Perpetual Preferred Stock ( IMA-PB). The di... an amount per share equal to the quotient of (a) ...
Breaking Biology Technology:VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 2VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 3VIA Pharmaceuticals Completes Patient Visits in Phase 2 Trial of VIA-2291 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Peregrine Pharmaceuticals to Report Second Quarter FY 2010 Financial Results 2
...ovember 28, Evotec AG (Frankfurt Stock Exchange: E...laus Maleck have been appointed to,the Company,s M...icer and,Chief Financial Officer., Jorn Aldag, Pr...id:,"I,m extremely pleased to announce the additio...anagement Board. Both are individuals with a wealt...
...asdaq:,PPDI) today announced the appointment of Jo... clinical operations, to lead the company,s delive... America and the Caribbean.,Based in Mexico City, ...PPD,clinical services in the region., "Dr. Viramo...tical,industry in Mexico, extensive clinical resea...
...ceutical Company Inc. (Nasdaq: NSTK ) announced t...ts Focus on Healthcare Conference on,Wednesday, De...llennium,Broadway Hotel in New York City., To acc...ease log on to,Nastech,s website at http://www.na...resentation in order to register and download any ...
Other Biology Technology:Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 2Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 3Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board 4Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean 2Viramontes to Lead PPD Clinical Operations in Mexico, Central America and the Caribbean 3
...ti-purpose, high gel-strength agarose suitable for...m conventional constant field to Pulsed Field Gel ...th and exclusion limits, Multi ABgarose can effect...nning times. This in turn means reduced band diffu...
...is a molecular screening, low melting point agaros...g. It is recommended for separation of nucleic aci...icro ABgarose is also suited to capillary electrop...ques. At a 3% concentration, Micro ABgarose gels a...
Sheep Anti-Salmonella Shoreditch Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-Drosophila Melanogaster Achaete protein Monoclonal Antibody, Unconjugated from Developmental Studies Hybridoma Bank
Biology Products: